Pusceddu S - Search Results

1

Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.

Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S, Sabella G, Del Gobbo A, Gobbo S, Ferrero S, Fabbri A, Pardo C, Garzone G, Prinzi N, Pusceddu S, Testi A, Rolli L, Mangogna A, Bercich L, Benvenuti MR, Bria E, Pilotto S, Berruti A, Pastorino U, Capella C, Infante M, Milella M, Scarpa A, Milione M. Simbolo M, et al. Among authors: pusceddu s. Virchows Arch. 2024 May;484(5):777-788. doi: 10.1007/s00428-023-03721-4. Epub 2024 Jan 3. Virchows Arch. 2024. PMID: 38168015 Free PMC article.

2

Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.

De Miglio MR, Simile MM, Muroni MR, Pusceddu S, Calvisi D, Carru A, Seddaiu MA, Daino L, Deiana L, Pascale RM, Feo F. De Miglio MR, et al. Among authors: pusceddu s. Mol Carcinog. 1999 May;25(1):21-9. Mol Carcinog. 1999. PMID: 10331741

3

Spartalizumab in metastatic, well/poorly-differentiated neuroendocrine neoplasms.

Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, Li D, Tafuto S, Raj N, Campana D, Hijioka S, Raderer M, Guimbaud R, Gajate P, Pusceddu S, Reising A, Degtyarev E, Shilkrut M, Eddy S, Singh S. Yao JC, et al. Among authors: pusceddu s. Endocr Relat Cancer. 2021 Jan 1:ERC-20-0382.R1. doi: 10.1530/ERC-20-0382. Online ahead of print. Endocr Relat Cancer. 2021. PMID: 33480358

4

Everolimus in advanced solid tumors: when to start, early or late?

Pusceddu S, Tessari A, Testa I, Procopio G. Pusceddu S, et al. Tumori. 2014 Jan-Feb;100(1):e2-3. doi: 10.1700/1430.15827. Tumori. 2014. PMID: 24675508

5

Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.

Pascale RM, De Miglio MR, Muroni MR, Simile MM, Daino L, Seddaiu MA, Pusceddu S, Gaspa L, Calvisi D, Manenti G, Feo F. Pascale RM, et al. Among authors: pusceddu s. Hepatology. 1998 Feb;27(2):452-61. doi: 10.1002/hep.510270220. Hepatology. 1998. PMID: 9462644

6

Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update.

Bajetta E, Catena L, Pusceddu S, Spada F, Iannacone C, Sarno I, Di Menna G, Dottorini L, Marte AM. Bajetta E, et al. Among authors: pusceddu s. Neuroendocrinology. 2018;106(4):307-311. doi: 10.1159/000479587. Epub 2017 Jul 26. Neuroendocrinology. 2018. PMID: 28743120 Clinical Trial.

7

Pancreatic well-differentiated neuroendocrine neoplasms (pWDNENs): what place for everolimus and sunitinib derived from ESMO clinical practice guidelines in the therapeutic algorithm?

Pusceddu S, Buzzoni R, De Braud F. Pusceddu S, et al. Ann Oncol. 2013 May;24(5):1415-6. doi: 10.1093/annonc/mdt102. Epub 2013 Mar 13. Ann Oncol. 2013. PMID: 23493138 Free article. No abstract available.

8

Real-world study of everolimus in advanced progressive neuroendocrine tumors.

Panzuto F, Rinzivillo M, Fazio N, de Braud F, Luppi G, Zatelli MC, Lugli F, Tomassetti P, Riccardi F, Nuzzo C, Brizzi MP, Faggiano A, Zaniboni A, Nobili E, Pastorelli D, Cascinu S, Merlano M, Chiara S, Antonuzzo L, Funaioli C, Spada F, Pusceddu S, Fontana A, Ambrosio MR, Cassano A, Campana D, Cartenì G, Appetecchia M, Berruti A, Colao A, Falconi M, Delle Fave G. Panzuto F, et al. Among authors: pusceddu s. Oncologist. 2015 May;20(5):570. doi: 10.1634/theoncologist.2014-0037erratum. Oncologist. 2015. PMID: 25956900 Free PMC article. No abstract available.

9

Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report.

Valente M, Catena L, Milione M, Pusceddu S, Formisano B, Bajetta E. Valente M, et al. Among authors: pusceddu s. Case Rep Oncol. 2010 Jul 2;3(2):202-207. doi: 10.1159/000317313. Case Rep Oncol. 2010. PMID: 20740197 Free PMC article.

10

Compassionate use of everolimus in a patient with a neuroendocrine tumor: a case report and discussion of the literature.

Pusceddu S, Milione M, Procopio G. Pusceddu S, et al. Oncol Res. 2011;19(8-9):403-6. doi: 10.3727/096504011x13123323849799. Oncol Res. 2011. PMID: 22329200 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters